Celanese Corporation experienced a notable downturn in financial performance in 2025, evidenced by declining revenues and persistent operating losses across its Engineered Materials and Acetyl Chain segments, driven by weaker economic conditions and competitive pressures. Despite this, the company maintains substantial operational cash flow and pursues targeted capital investments to support select growth initiatives. Its near-term outlook centers on navigating economic headwinds while addressing leverage covenant challenges through deleveraging and cost-efficiency programs. Monitoring revenue recovery, margin stabilization, and successful capital allocation will be key milestones for validating strategic execution.